360biolabs is a contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics in a quality-assured environment.
We provide pharmacokinetic (PK) and pharmacodynamic (PD) services for clinical trials and preclinical studies to support a diverse range of therapeutic areas.
360biolabs is based in Melbourne Australia, regarded as the biotech capital of the southern hemisphere. Australia is a technically modern country with a very diverse multi-cultural population, ideal for robust clinical trials.
Highly complementary transaction adds virology, immunology and LC-MS/MS small molecule expertise to BioAgilytix, a global leader in bioanalytical services in biologics drug development.